Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women.

被引:244
作者
Fung, TT [1 ]
Hu, FB
McCullough, ML
Newby, PK
Willett, WC
Holmes, MD
机构
[1] Simmons Coll, Dept Nutr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[3] Amer Canc Soc, Atlanta, GA 30329 USA
[4] Tufts Univ, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA
关键词
breast cancer; diet; nutrition; estrogen receptor;
D O I
10.1093/jn/136.2.466
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Emerging evidence suggests that diet quality indices may serve as prognostic indicators of disease. However, the ability of these indices to predict breast cancer risk has not been evaluated previously. We assessed the association between several diet quality scores and the risk of breast cancer in postmenopausal women. The indices we used were the Healthy Eating Index (HEI), Alternate Healthy Eating Index (AHEI), Diet Quality Index-Revised (DQI-R), Recommended Food Score (RFS), and the alternate Mediterranean Diet Score (aMed). We calculated diet quality indices from dietary information collected in FFQ administered 5 times between 1984 and 1998 among women in the Nurses' Health Study cohort. Relative risks (RR) were computed using Cox proportional hazards models and adjusted for known risk factors for breast cancer. Separate analyses were conducted for estrogen receptor positive (ER+) and negative (ER-) tumors. Between 1984 and 2002, we documented 3580 cases of breast cancer, of which 2367 were ER+, and 575 were ER-. We did not observe any association between the diet quality indices and total or ER+ breast cancer risk. However, for ER- breast cancer, after adjusting for potential confounders, the FIR comparing highest to lowest quintiles were 0.78 (95% Cl = 0.59-1.04, P for trend = 0.01) for the AHEI, 0.69 (95% Cl = 0.51-0.94, P for trend = 0.003) for the RFS, and 0.79 (95% Cl = 0.60-1.03, P for trend = 0.03) for the aMed. These observations appeared to be the result of an inverse association (P for trend = 0.01) with the vegetable component of the scores. We conclude that women who scored high in AHEI, RFS, and aMed had a lower risk of ER- breast cancer. The HEI and DQI-R appeared to be of limited value in predicting breast cancer risk.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 50 条
[21]   Role of Androgen Excess in the Development of Estrogen Receptor-positive and Estrogen Receptor-negative Breast Cancer [J].
Secreto, Giorgio ;
Zumoff, Barnett .
ANTICANCER RESEARCH, 2012, 32 (08) :3223-3228
[22]   Metabolic differences in estrogen receptor-negative breast cancer based on androgen receptor status [J].
Noh, Songmi ;
Kim, Ji-Ye ;
Koo, Ja Seung .
TUMOR BIOLOGY, 2014, 35 (08) :8179-8192
[23]   Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort [J].
Karin Elebro ;
Salma Butt ;
Mozhgan Dorkhan ;
Helena Jernström ;
Signe Borgquist .
Cancer Causes & Control, 2014, 25 :945-957
[24]   Diet quality and BRCA-associated breast cancer risk [J].
A. Nkondjock ;
P. Ghadirian .
Breast Cancer Research and Treatment, 2007, 103 :361-369
[25]   Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmo Diet and Cancer Cohort [J].
Elebro, Karin ;
Butt, Salma ;
Dorkhan, Mozhgan ;
Jernstrom, Helena ;
Borgquist, Signe .
CANCER CAUSES & CONTROL, 2014, 25 (08) :945-957
[26]   Diet quality and BRCA-associated breast cancer risk [J].
Nkondjock, A. ;
Ghadirian, P. .
BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (03) :361-369
[27]   Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases [J].
Nass, Norbert ;
Ignatov, Atanas ;
Andreas, Ludwig ;
Weissenborn, Christine ;
Kalinski, Thomas ;
Sel, Saadettin .
HISTOCHEMISTRY AND CELL BIOLOGY, 2017, 147 (05) :625-634
[28]   Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases [J].
Norbert Nass ;
Atanas Ignatov ;
Ludwig Andreas ;
Christine Weißenborn ;
Thomas Kalinski ;
Saadettin Sel .
Histochemistry and Cell Biology, 2017, 147 :625-634
[29]   A genome-wide association scan on estrogen receptor-negative breast cancer [J].
Jingmei Li ;
Keith Humphreys ;
Hatef Darabi ;
Gustaf Rosin ;
Ulf Hannelius ;
Tuomas Heikkinen ;
Kristiina Aittomäki ;
Carl Blomqvist ;
Paul DP Pharoah ;
Alison M Dunning ;
Shahana Ahmed ;
Maartje J Hooning ;
Antoinette Hollestelle ;
Rogier A Oldenburg ;
Lars Alfredsson ;
Aarno Palotie ;
Leena Peltonen-Palotie ;
Astrid Irwanto ;
Hui Qi Low ;
Garrett HK Teoh ;
Anbupalam Thalamuthu ;
Juha Kere ;
Mauro D'Amato ;
Douglas F Easton ;
Heli Nevanlinna ;
Jianjun Liu ;
Kamila Czene ;
Per Hall .
Breast Cancer Research, 12
[30]   Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomas [J].
Traub, F ;
Jost, M ;
Hess, R ;
Schorn, K ;
Menzel, C ;
Budde, P ;
Schulz-Knappek, P ;
Lamping, N ;
Pich, A ;
Kreipe, H ;
Tammen, H .
LABORATORY INVESTIGATION, 2006, 86 (03) :246-253